(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.60 | 5.90 | -22.03 | 8.89 | 2.05 | 333.66 | 2.95 | 7.89 | -62.61 |
| PBIDT | 4.42 | 5.36 | -17.54 | 8.20 | 0.38 | 2057.89 | 0.86 | 3.84 | -77.60 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 4.42 | 5.36 | -17.54 | 8.20 | 0.38 | 2057.89 | 0.86 | 3.84 | -77.60 |
| Depreciation | 0.02 | 0.03 | -33.33 | 0.04 | 0.06 | -33.33 | 0.13 | 0.19 | -31.58 |
| PBT | 4.40 | 5.33 | -17.45 | 8.16 | 0.32 | 2450.00 | 0.73 | 3.65 | -80.00 |
| TAX | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | 0.26 | -1.95 | -113.33 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.04 | -0.30 | 246.67 |
| PAT | 4.40 | 5.35 | -17.76 | 8.16 | 0.34 | 2300.00 | 0.47 | 5.60 | -91.61 |
| Equity | 15.00 | 15.00 | 0.00 | 15.00 | 15.00 | 0.00 | 15.00 | 15.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.50 |
| Dr. Reddys Lab | 1230.00 |
| Cipla | 1236.55 |
| Zydus Lifesciences | 945.85 |
| Lupin | 2307.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: